Alba’s management team has over 120 years of combined experience in executive management positions in major pharmaceutical, biotechnology and specialty pharmaceutical firms. They have been involved in the development of more than 13 therapeutic macromolecules. 10 small molecule pharmaceuticals and 10 drug product launches over the past 20 years. In the hands of this experienced team, Alba's intellectual property position and lead candidates will allow for its’ first drug registration within the next 3 to 4 years.

Alba's Scientific Advisory Board and Development Advisory Board members are respected experts in their respective fields from industry and academia.   These top-ranked advisors include experts in the fields of barrier function, physiology, toxicology, statistics, celiac disease, type 1 diabetes and other other autoimmune and inflammatory diseases.